Announcement

Collapse
No announcement yet.

SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection

    Sci Rep. 2017 Aug 4;7(1):7262. doi: 10.1038/s41598-017-07724-5.
    SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection.

    Fino KK1, Yang L1, Silveyra P1,2, Hu S1, Umstead TM1, DiAngelo S1, Halstead ES1,3,4, Cooper TK5,6, Abraham T7, Takahashi Y8, Zhou Z9, Wang HG10,11, Chroneos ZC12,13.
    Author information

    Abstract

    New influenza A viruses that emerge frequently elicit composite inflammatory responses to both infection and structural damage of alveolar-capillary barrier cells that hinders regeneration of respiratory function. The host factors that relinquish restoration of lung health to enduring lung injury are insufficiently understood. Here, we investigated the role of endophilin B2 (B2) in susceptibility to severe influenza infection. WT and B2-deficient mice were infected with H1N1 PR8 by intranasal administration and course of influenza pneumonia, inflammatory, and tissue responses were monitored over time. Disruption of B2 enhanced recovery from severe influenza infection as indicated by swift body weight recovery and significantly better survival of endophilin B2-deficient mice compared to WT mice. Compared to WT mice, the B2-deficient lungs exhibited induction of genes that express surfactant proteins, ABCA3, GM-CSF, podoplanin, and caveolin mRNA after 7 days, temporal induction of CCAAT/enhancer binding protein CEBPα, β, and δ mRNAs 3-14 days after infection, and differences in alveolar extracellular matrix integrity and respiratory mechanics. Flow cytometry and gene expression studies demonstrated robust recovery of alveolar macrophages and recruitment of CD4+ lymphocytes in B2-deficient lungs. Targeting of endophilin B2 alleviates adverse effects of IAV infection on respiratory and immune cells enabling restoration of alveolar homeostasis.


    PMID: 28779131 PMCID: PMC5544693 DOI: 10.1038/s41598-017-07724-5
    Free full text
Working...
X